Greetings, and welcome to the INmune Bio’s. 2024 Fourth Quarter and Full Year Earnings Call. At this time, all participants are in a listen-only mode. [Operator Instructions]. As a reminder, this ...
Total Revenue-- $1.7 million in revenue for Q2 2025, up 49% year-over-year and 6% sequentially, reflecting broad segment growth. Hardware Revenue Increase-- Hardware revenue increased by $458,000 in ...
The active ingredient of CORDStrom for RDEB is formally named pobistrocel, with the commercial drug name Ebstracel chosen for this formulation. Submission to the U.K. Medicines and Healthcare products ...
Operator: Greetings, and welcome to the INmune Bio’s 2026 First Quarter Earnings Call. As a reminder, this conference is being recorded. A transcript will follow within 24 hours of this conference ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results